Merck | MRK - Gross Profit On Sales

Stock Price
121.45
Daily Change
-0.60 -0.49%
Monthly
-4.63%
Yearly
-13.34%
Q1 Forecast
121.85

Merck reported EUR3.21B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Adidas EUR 3.44B 358M Sep/2025
Adyen EUR 1.08B 788.66M Dec/2024
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.46B 70M Sep/2025
Amadeus IT EUR 733.8M 486.7M Sep/2025
Amarin USD 22.21M 28.15M Sep/2025
AstraZeneca USD 12.39B 406M Sep/2025
BASF EUR 3.16B 1.02B Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 488M 64M Sep/2025
Danone EUR 6.82B 23M Dec/2024
Fresenius EUR 1.3B 158M Sep/2025
Fresenius Medical Care EUR 1.24B 27M Sep/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 868M 195M Jun/2025
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Infineon EUR 1.5B 11M Sep/2025
Linde USD 4.24B 47M Sep/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.21B 186M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Philips EUR 1.91B 100M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 2.46B 520M Dec/2024